Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finn Sellebjerg

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Danish Medical Bulletin|July 13, 2005
Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosisFinn Sellebjerg
Multiple Sclerosis and Related Disorders|April 17, 2015
Interleukin-2 effect on T cell activation revealed by daclizumab treatmentFinn Sellebjerg
The Lancet. Neurology|February 19, 2022
The prognostic value of neurofilament light chain in serumFinn Sellebjerg, Melinda Magyari
Nature Reviews. Neurology|June 17, 2015
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?Finn Sellebjerg, Annette Bang Oturai
Ugeskrift for Laeger|June 21, 2008
[Biological treatment of multiple sclerosis]Per Soelberg Sørensen, Finn Sellebjerg
Lancet (London, England)|October 31, 2008
Oral fumarate for relapsing-remitting multiple sclerosisPer Soelberg Sorensen, Finn Sellebjerg
Current Opinion in Neurology|March 30, 2021
Targeting B cells in multiple sclerosisFinn Sellebjerg, Martin S Weber
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2016
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosisPer Soelberg Sorensen, Finn Sellebjerg
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2022
All anti-CD20 monoclonal antibodies have similar efficacy and risks: NoFinn Sellebjerg, Jeppe Romme Christensen
Therapeutic Advances in Neurological Disorders|April 5, 2019
Pulsed immune reconstitution therapy in multiple sclerosisPer Soelberg Sorensen, Finn Sellebjerg
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Danish Medical Bulletin|July 13, 2005
Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosisFinn Sellebjerg
Multiple Sclerosis and Related Disorders|April 17, 2015
Interleukin-2 effect on T cell activation revealed by daclizumab treatmentFinn Sellebjerg
The Lancet. Neurology|February 19, 2022
The prognostic value of neurofilament light chain in serumFinn Sellebjerg, Melinda Magyari
Nature Reviews. Neurology|June 17, 2015
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?Finn Sellebjerg, Annette Bang Oturai
Ugeskrift for Laeger|June 21, 2008
[Biological treatment of multiple sclerosis]Per Soelberg Sørensen, Finn Sellebjerg
Lancet (London, England)|October 31, 2008
Oral fumarate for relapsing-remitting multiple sclerosisPer Soelberg Sorensen, Finn Sellebjerg
Current Opinion in Neurology|March 30, 2021
Targeting B cells in multiple sclerosisFinn Sellebjerg, Martin S Weber
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2016
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosisPer Soelberg Sorensen, Finn Sellebjerg
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2022
All anti-CD20 monoclonal antibodies have similar efficacy and risks: NoFinn Sellebjerg, Jeppe Romme Christensen
Therapeutic Advances in Neurological Disorders|April 5, 2019
Pulsed immune reconstitution therapy in multiple sclerosisPer Soelberg Sorensen, Finn Sellebjerg
Pageof 25